跳至主要内容
临床试验/NCT06169566
NCT06169566尚未招募不适用

Analysis of Gut Microbiome in Thai Women With Polycystic Ovary Syndrome and the Synbiotics Effect on Reproductive and Cardiovascular Risk: A Randomized Controlled Trial

Maharaj Nakorn Chiang Mai Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40
试验地点
2
主要终点
Gut microbiome in polycystic ovary syndrome

研究概览

简要总结

The goal of this clinical trial is to compare the effect of synbiotics and placebo in Thai women with polycystic ovary syndrome. The main questions it aims to answer are:

  • Do synbiotics have a positive effect on the gut microbiome?
  • Do synbiotics have a positive effect on reproductive outcomes?
  • Do synbiotics have a positive effect on cardiovascular outcomes? Participants will be randomized, and blinded to receive either synbiotics or placebo.

While placebo is a comparison group: Researchers will compare with placebo to see if the effects on reproductive and cardiovascular risk differ.

详细描述

Analysis of gut microbiome in Thai women with polycystic ovary syndrome and the synbiotics effect on reproductive and cardiovascular risk: A randomized controlled trial

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Gut microbiome in polycystic ovary syndrome

时间窗: 12 months

Gut microbiome will be evaluated by metagenomic analysis of the stool exam of PCOS patient before and after receive synbiotics

次要结局

  • synbiotics effect on reproductive and cardiovascular risk(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ploywarong Rueangket

MD.

Maharaj Nakorn Chiang Mai Hospital

研究点 (2)

Loading locations...

相似试验